CAS has migrated to this web app on 5/23/21. If you have an active membership on 5/23/21, log in with your email and password. Otherwise, please create a new account.
Fourty antibody deals were closed at a total value of ~ $14.7 billion in 2021. Twenty two of them were in-licensing deals; eighteen were out-licensing deals.Read Story
Canada ranks fourth in global health and biosciences hubs. Canadian biotech companies are nimble, dynamic, and focused. In this article, we will take a deep dive into some of the mRead Story